TABLE 2.
Immunosuppressive maintenance therapy post-discharge by type of organ transplant.
| Kidney | Liver | Heart | Lung | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | +cortico steroids | N | % | +cortico steroids | N | % | +cortico steroids | N | % | +cortico steroids | |
| TAC-based | 2,835 | 70.4 | 2,315 | 1867 | 84.1 | 1,521 | 66 | 15.0 | 59 | 123 | 57.2 | 114 |
| Mono | 261 | 6.5 | 210 | 927 | 41.8 | 786 | 21 | 4.8 | 19 | 42 | 19.5 | 36 |
| + antimet | 1980 | 49.1 | 1,682 | 690 | 31.1 | 579 | 45 | 10.3 | 40 | 81 | 37.7 | 78 |
| + mTOR | 559 | 13.9 | 398 | 211 | 9.5 | 129 | — | — | — | — | — | — |
| Other | 35 | 0.9 | 25 | 39 | 1.8 | 27 | — | — | — | — | — | — |
| CsA-based | 787 | 19.5 | 564 | 271 | 12.2 | 198 | 333 | 77.0 | 258 | 76 | 35.3 | 71 |
| Mono | 85 | 2.1 | 74 | 225 | 10.1 | 162 | 84 | 19.8 | 64 | 13 | 6.0 | 12 |
| + antimet | 617 | 15.3 | 416 | 39 | 1.8 | 34 | 231 | 52.8 | 181 | 63 | 29.3 | 59 |
| + mTOR | 79 | 2.0 | 69 | 7 | 0.3 | 2 | 14 | 3.4 | 10 | — | — | — |
| Other | 6 | 0.1 | 5 | — | — | — | 4 | 0.9 | 3 | — | — | — |
| No-CNI | 407 | 10.1 | 381 | 81 | 3.7 | 69 | 35 | 8.0 | 26 | 16 | 7.4 | 6 |
| + antimet | 78 | 1.9 | 60 | 16 | 0.7 | 12 | 17 | 3.9 | 9 | 10 | 4.7 | 6 |
| + mTOR | 30 | 0.7 | 27 | 16 | 0.7 | 11 | 2 | 0.5 | 1 | — | — | — |
| Other | 299 | 7.4 | 294 | 49 | 2.2082 | 46 | 16 | 3.7 | 16 | 6 | 2.8 | 6 |
| Total | 4,029 | 100% | 3,260 | 2,219 | 100% | 1788 | 433 | 100% | 343 | 215 | 100% | 191 |